Immunovia AB(DE:1YR)
€0.010.00 (0.00%)
DE:1YR
Immunovia AB Revenue
€0.01
At close:0.00 (0.00%)
Immunovia AB (1YR) Revenue
1 Followers
Immunovia AB Revenue
Immunovia AB had a revenue of 843.00K in the quarter ending Sep 30, 2026, with 121.26%. This bring the company's revenue in the last twelve months to 1.95M, Increased 61.32%. In the fiscal year ending Dec 31, 2025, Immunovia AB had annual revenue of 685.00K with -26.42% growth.
- Revenue (ttm)
- 1.95M
- Revenue Growth
- 157.39%
- P/S Ratio
- 11.59
- Revenue/Employee
- EUR 38,056
- Employees
- 18
- Market Cap
- EUR 7.94M
Revenue Chart
Immunovia AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 685.00K | -246.00K | -26.42% |
| Dec 31, 2024 | 931.00K | -644.00K | -40.89% |
| Dec 31, 2023 | 1.57M | 430.00K | 37.55% |
| Dec 31, 2022 | 1.15M | 301.00K | 35.66% |
| Dec 31, 2021 | 844.00K | 482.00K | 133.15% |
| Dec 31, 2020 | 362.00K | 6.00K | 1.69% |
| Dec 31, 2019 | 356.00K | 23.41K | 7.04% |
| Dec 31, 2018 | 332.60K | 183.63K | 123.27% |
| Dec 31, 2017 | 148.96K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| DE:1YR | 1.95M |
| SE:QLINEA | 11.19M |
| SE:ACARIX | 9.22M |
| SE:BIOVIC.B | 14.83M |
| SE:DVYSR | 253.70M |